Although the AOM cohort had a higher percentage with a Chronic Disease Score 2 than the non-AOM cohort (52.25% vs 8.44%
Below is a tiny sample of Reddit and Facebook threads that capture common themes from patients and clinicians navigating long term GLP-1 use: Closing Thoughts Long term use and discontinuing GLP-1s is unlikely to follow a single, uniform pathway
Heme-oxygenase I and PCG-1alpha regulate mitochondrial biogenesis via microglial activation of Alpha7 nicotinic acetylcholine receptors using PNU282987
Options for switching include trying a different compounder, switching to branded semaglutide if accessible, or exploring alternative GLP-1 medications like tirzepatide
Survodutide A dual GLP-1/glucagon agonist for weight loss, liver fat reduction, and metabolic health
When you stop the medication, all of these effects reverse